ADAPT technique in ischemic stroke treatment of M2 middle cerebral artery occlusions in comparison to M1 occlusions: Post hoc analysis of the PROMISE study

Standard

ADAPT technique in ischemic stroke treatment of M2 middle cerebral artery occlusions in comparison to M1 occlusions: Post hoc analysis of the PROMISE study. / Navia, Pedro; Schramm, Peter; Fiehler, Jens; PROMISE Study Investigators.

in: INTERV NEURORADIOL, Jahrgang 26, Nr. 2, 04.2020, S. 178-186.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{88919ca74bf14633a004bdb12424960b,
title = "ADAPT technique in ischemic stroke treatment of M2 middle cerebral artery occlusions in comparison to M1 occlusions: Post hoc analysis of the PROMISE study",
abstract = "BACKGROUND/PURPOSE: The benefit of endovascular thrombectomy in acute ischemic stroke (AIS) therapy of proximal large vessel occlusions (LVO) is established. However, there are few prospective studies evaluating the use of a direct aspiration first pass technique in distal vessel occlusions. This post hoc analysis of the PROMISE study examines the safety and effectiveness of the Penumbra System with the ACE68 and ACE64 Reperfusion Catheters for aspiration thrombectomy in the M1 and M2 segments of the middle cerebral artery.METHODS: PROMISE is a prospective, multicenter study that enrolled 204 patients with anterior circulation LVO AIS-treated frontline with ACE68/ACE64 catheters. We compared clinical and angiographic outcomes, complications, and mortality in patients with M1 and M2 occlusions. The association of M1 and M2 location and functional independence or mTICI 2b-3 reperfusion was described in univariable and multivariable analyses.RESULTS: One hundred sixty-one patients (124 M1 and 37 M2 locations) met the study criteria. Post procedure mTICI 2b-3 reperfusion (93% vs. 92%, p = 1.00), functional independence (57% vs. 70%, p = 0.18), symptomatic intracranial hemorrhage (1.6% vs. 2.7%, p = 0.55), device- or procedure-related serious adverse events at 30 days (4.0% vs. 8.1%, p = 0.39), and mortality at 90 days (6.6% vs. 2.7%, p = 0.69) were comparable between M1 and M2 occlusions. In multivariable analysis, lower age, lower baseline NIHSS, and shorter time from onset to admission were independent predictors of functional independence.CONCLUSIONS: For frontline aspiration thrombectomy of stroke, use of large-bore ACE68/ACE64 catheters for treatment of M2 occlusions appeared as safe and effective as for M1 occlusions.",
keywords = "Adult, Aged, Aged, 80 and over, Arterial Occlusive Diseases/surgery, Catheters, Cerebral Angiography, Cerebral Revascularization, Female, Humans, Infarction, Middle Cerebral Artery/surgery, Ischemic Stroke/mortality, Male, Middle Aged, Neurosurgical Procedures/adverse effects, Postoperative Complications/epidemiology, Prospective Studies, Reperfusion, Stents, Treatment Outcome",
author = "Pedro Navia and Peter Schramm and Jens Fiehler and {PROMISE Study Investigators}",
year = "2020",
month = apr,
doi = "10.1177/1591019919894800",
language = "English",
volume = "26",
pages = "178--186",
journal = "INTERV NEURORADIOL",
issn = "1591-0199",
publisher = "Centauro srl",
number = "2",

}

RIS

TY - JOUR

T1 - ADAPT technique in ischemic stroke treatment of M2 middle cerebral artery occlusions in comparison to M1 occlusions: Post hoc analysis of the PROMISE study

AU - Navia, Pedro

AU - Schramm, Peter

AU - Fiehler, Jens

AU - PROMISE Study Investigators

PY - 2020/4

Y1 - 2020/4

N2 - BACKGROUND/PURPOSE: The benefit of endovascular thrombectomy in acute ischemic stroke (AIS) therapy of proximal large vessel occlusions (LVO) is established. However, there are few prospective studies evaluating the use of a direct aspiration first pass technique in distal vessel occlusions. This post hoc analysis of the PROMISE study examines the safety and effectiveness of the Penumbra System with the ACE68 and ACE64 Reperfusion Catheters for aspiration thrombectomy in the M1 and M2 segments of the middle cerebral artery.METHODS: PROMISE is a prospective, multicenter study that enrolled 204 patients with anterior circulation LVO AIS-treated frontline with ACE68/ACE64 catheters. We compared clinical and angiographic outcomes, complications, and mortality in patients with M1 and M2 occlusions. The association of M1 and M2 location and functional independence or mTICI 2b-3 reperfusion was described in univariable and multivariable analyses.RESULTS: One hundred sixty-one patients (124 M1 and 37 M2 locations) met the study criteria. Post procedure mTICI 2b-3 reperfusion (93% vs. 92%, p = 1.00), functional independence (57% vs. 70%, p = 0.18), symptomatic intracranial hemorrhage (1.6% vs. 2.7%, p = 0.55), device- or procedure-related serious adverse events at 30 days (4.0% vs. 8.1%, p = 0.39), and mortality at 90 days (6.6% vs. 2.7%, p = 0.69) were comparable between M1 and M2 occlusions. In multivariable analysis, lower age, lower baseline NIHSS, and shorter time from onset to admission were independent predictors of functional independence.CONCLUSIONS: For frontline aspiration thrombectomy of stroke, use of large-bore ACE68/ACE64 catheters for treatment of M2 occlusions appeared as safe and effective as for M1 occlusions.

AB - BACKGROUND/PURPOSE: The benefit of endovascular thrombectomy in acute ischemic stroke (AIS) therapy of proximal large vessel occlusions (LVO) is established. However, there are few prospective studies evaluating the use of a direct aspiration first pass technique in distal vessel occlusions. This post hoc analysis of the PROMISE study examines the safety and effectiveness of the Penumbra System with the ACE68 and ACE64 Reperfusion Catheters for aspiration thrombectomy in the M1 and M2 segments of the middle cerebral artery.METHODS: PROMISE is a prospective, multicenter study that enrolled 204 patients with anterior circulation LVO AIS-treated frontline with ACE68/ACE64 catheters. We compared clinical and angiographic outcomes, complications, and mortality in patients with M1 and M2 occlusions. The association of M1 and M2 location and functional independence or mTICI 2b-3 reperfusion was described in univariable and multivariable analyses.RESULTS: One hundred sixty-one patients (124 M1 and 37 M2 locations) met the study criteria. Post procedure mTICI 2b-3 reperfusion (93% vs. 92%, p = 1.00), functional independence (57% vs. 70%, p = 0.18), symptomatic intracranial hemorrhage (1.6% vs. 2.7%, p = 0.55), device- or procedure-related serious adverse events at 30 days (4.0% vs. 8.1%, p = 0.39), and mortality at 90 days (6.6% vs. 2.7%, p = 0.69) were comparable between M1 and M2 occlusions. In multivariable analysis, lower age, lower baseline NIHSS, and shorter time from onset to admission were independent predictors of functional independence.CONCLUSIONS: For frontline aspiration thrombectomy of stroke, use of large-bore ACE68/ACE64 catheters for treatment of M2 occlusions appeared as safe and effective as for M1 occlusions.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Arterial Occlusive Diseases/surgery

KW - Catheters

KW - Cerebral Angiography

KW - Cerebral Revascularization

KW - Female

KW - Humans

KW - Infarction, Middle Cerebral Artery/surgery

KW - Ischemic Stroke/mortality

KW - Male

KW - Middle Aged

KW - Neurosurgical Procedures/adverse effects

KW - Postoperative Complications/epidemiology

KW - Prospective Studies

KW - Reperfusion

KW - Stents

KW - Treatment Outcome

U2 - 10.1177/1591019919894800

DO - 10.1177/1591019919894800

M3 - SCORING: Journal article

C2 - 31847643

VL - 26

SP - 178

EP - 186

JO - INTERV NEURORADIOL

JF - INTERV NEURORADIOL

SN - 1591-0199

IS - 2

ER -